Esmeron 10mg / 1ml Injection
PDF Leaflet Revision Date: 30 August 2017
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to general anaesthesia for tracheal intubation and muscle relaxation.
Dosage (summary)
0.6 mg/kg for intubation; maintenance 0.15 mg/kg.
Onset of Action / Duration
Onset: 60-90 secs, Duration: 30-50 mins
Special Populations
- Geriatric patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not demonstrated; use with caution.
Key Drug Interactions
- Halogenated volatile anaesthetics
- Aminoglycoside antibiotics
- Corticosteroids
Contraindications
- Hypersensitivity to rocuronium
- Neonates
- Paediatric and geriatric patients for mechanical ventilation
Common side effects
- Injection site pain
- Prolonged neuromuscular block
- Hypotension
Counselling Points
- Monitor for respiratory function post-administration.
- Avoid driving or operating machinery for 24 hours post-recovery.
- Titrate dosage based on neuromuscular monitoring.
Serious warnings
- Anaphylaxis risk
- Residual curarisation
- Prolonged paralysis in ICU
Important Disclaimer
The Esmeron 10mg / 1ml Injection professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
